Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Young-il Hwnag
The Anti-Fibrotic Effect of GV1001 Combined With Gemcitabine on Treatment of Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
Related publications
Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer
Suizo
Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
Frontiers in Oncology
Cancer Research
Oncology
The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine
Scientific Reports
Multidisciplinary
Pancreatic Ductal Adenocarcinoma With Cystic Features
HPB
Hepatology
Gastroenterology
Front Cover: A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma (ChemMedChem 15/2019)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Correction: Inhibition of HIF-1α By PX-478 Enhances the Anti-Tumor Effect of Gemcitabine by Inducing Immunogenic Cell Death in Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
Tumoral EHF Predicts the Efficacy of Anti-Pd1 Therapy in Pancreatic Ductal Adenocarcinoma
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma
European Journal of Cancer
Cancer Research
Oncology
Development and in Vitro Characterization of a Gemcitabine-Loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
